Get started
Author

Joaquín Borrás-Blasco

Observed names: Joaquin Borrás-Blasco, Joaquín BORRÁS-BLASCO, Joaquín Borras‐Blasco, Joaquín Borrás‐Blasco
Institution: Hospital de Sagunto
Observed institution: Hospital de Sagunto
ORCID: 0000-0003-0248-4208
Observed ORCID: 0000-0003-0248-4208
OpenAlex ID: A5122452786
Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases
2006 · José Carlos Pascual, Jaime Matarredona, et al. · International Journal of Dermatology · 40
Economic Burden of Hidradenitis Suppurativa in Spain
2026 · Eva Vilarrasa, Joaquín Borrás-Blasco, et al. · Dermatology and Therapy · 2
PDF
Dosing interval optimization and persistence with faricimab in age-related macular degeneration: An observational study in real-world clinical practice
2026 · Silvia Cornejo-Uixeda, Joaquín Borrás-Blasco, et al. · Farmacia Hospitalaria · 2
Higher anticholinergic burden is associated with increased medium‐ and long‐term mortality following hip fracture: A systematic review and meta‐analysis
2026 · Alejandro Valcuende‐Rosique, Elisa García Tercero, et al. · British Journal of Clinical Pharmacology
Letter to the editor regarding “Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice”
2026 · Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, et al. · Neurodegenerative Disease Management
Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety
2026 · Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, et al. · Therapeutic Advances in Gastroenterology
[Artículo traducido] Optimización del intervalo de administración y persistencia con faricimab en la degeneración macular asociada a la edad: un estudio observacional en la práctica clínica real
2026 · Silvia Cornejo-Uixeda, Joaquín Borrás-Blasco, et al. · Farmacia Hospitalaria
Safety profile of tofersen in amyotrophic lateral sclerosis: a systematic review and meta-analysis
2026 · Francisco José Tarazona-Santabalbina, Angel Belenguer-Varea, et al. · Neurological Sciences
Comment on: Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study
2026 · Joaquín BORRÁS-BLASCO, Alejandro VALCUENDE-ROSIQUE, et al. · Italian Journal of Dermatology and Venereology
Persistence to palbociclib treatment in HR+/HER2– breast cancer patients: A real-world study
2026 · Alejandro Valcuende-Rosique, Dolores Rosique-Robles, et al. · Journal of Oncology Pharmacy Practice
Letter to the Editor “Use and Persistence of Beta 3‐Adrenoceptor Agonists for the Treatment of Overactive Bladder”
2026 · Joaquín Borrás‐Blasco, Alejandro Valcuende‐Rosique, et al. · International Journal of Urology
Works count: 11
Citation count: 44
H-index: 2
I10-index: 1
Year
Topic
Type